Clarentis Overview

Founded 2010
Status Private
Employees 3
Latest Deal Type Series A
Latest Deal Amount $10M
Latest Deal Amount

Clarentis General Information


Manufacturer of non-toxic disinfectant and anti-microbial products created to generate high-quality, pure HOCl from to produce the biocidal disinfectant. The company's disinfectant and anti-microbial products kill common bacteria across a broad spectrum of applications and also eradicate antibiotic-resistant strains of the virulent pathogens found around the globe, enabling customers to reduce the number of chemicals that they use to purify.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Primary Office
  • 4440 PGA Boulevard
  • Suite 600
  • Palm Beach Gardens, FL 33410
  • United States
+1 (561) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Clarentis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Sep-2014 $10M 0000 Completed Generating Revenue

Clarentis Executive Team (2)

Name Title Board Seat Contact Info
Duke Kalken Chief Executive Officer

1 Former Executive

Ready to get started?

Request a free trial